NCT04428099

Brief Summary

The main objective of the study will be to evaluate the effectiveness of an adjuvant lifestyle-based intervention for treatment-resistant patients with major depressive disorder. Patients will be allocated to one of these three groups: 1)Treatment prescribed by their mental health team plus written lifestyle change suggestions 2)Treatment prescribed by their mental health team plus written lifestyle change suggestions plus 8-week Mindfulness-based cognitive therapy (MBCT) program 3) Treatment prescribed by their mental health team plus written lifestyle change suggestions plus 8-week lifestyle change promotion program. We will collect patient data using the questionnaires administered at baseline, immediately after the intervention, and at six and 12-month follow-up. The primary outcome will be depression severity and secondary outcomes will include health-related quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
186

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 13, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2022

Completed
Last Updated

June 11, 2020

Status Verified

June 1, 2020

Enrollment Period

2 years

First QC Date

June 9, 2020

Last Update Submit

June 10, 2020

Conditions

Keywords

heallthy LifestyleMinfullness based cognitive therapyTeletherapy

Outcome Measures

Primary Outcomes (1)

  • Depression severity

    Beck Depression Inventory-II (BDI-II)

    12 month

Secondary Outcomes (1)

  • Health-related quality of life

    12 month

Study Arms (3)

Intervention

EXPERIMENTAL

Lifestyle change promotion program

Behavioral: Lifestyle change promotion programBehavioral: Written Information

Control 1

ACTIVE COMPARATOR

MBCT program

Behavioral: Mindfullness based cognitive programBehavioral: Written Information

Control 2

PLACEBO COMPARATOR

Usual care

Behavioral: Written Information

Interventions

The intervention consists of 8 group sessions centered on healthy physical activity, healthy diet, social life, Good Sleep Hygiene, healthy sun exposure, nature contact, how to stop ruminating, review and maintenance tips.

Intervention

The intervention consists of 8 group sessions with a mindfulness-based cognitive program

Control 1

Written information about lifestyle change suggestions

Control 1Control 2Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 18 or older.
  • Diagnosis of Major Depressive Disorder as stated by the DSM-5.
  • Two previous treatment failures (non-response to an adequate dose of potentially effective medication for an adequate length of time or treatment intolerance or refusal) in the current episode.
  • At least one month of treatment with a psychiatrist and/or psychologist in the current episode.
  • Physical and cognitive aptitudes to understand and give written informed consent.

You may not qualify if:

  • Comorbidity with other medical conditions which would affect the Central Nervous System (CNS).
  • Other severe psychiatric disorders (except for anxiety disorders or personality disorders)
  • Other non-controlled severe medical diseases, infectious or degenerative which would interfere with affective symptomatology or the adherence to the hygienic-dietary recommendations.
  • Patients with delusions or hallucinations which are congruent or non-congruent with mood.
  • Patients with an important risk for suicide

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitat Illes Balears

Palma de Mallorca, Balearic Islands, 07122, Spain

RECRUITING

Related Publications (1)

  • Navarro C, Yanez AM, Garcia A, Segui A, Gazquez F, Marino JA, Ibarra O, Serrano-Ripoll MJ, Gomez-Juanes R, Bennasar-Veny M, Salva J, Olivan B, Roca M, Gili M, Garcia-Toro M. Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic: A randomized clinical trial protocol. Medicine (Baltimore). 2020 Nov 6;99(45):e22958. doi: 10.1097/MD.0000000000022958.

MeSH Terms

Conditions

Depressive Disorder, Treatment-Resistant

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Central Study Contacts

Mauro García-Toro, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2020

First Posted

June 11, 2020

Study Start

January 13, 2020

Primary Completion

January 12, 2022

Study Completion

July 12, 2022

Last Updated

June 11, 2020

Record last verified: 2020-06

Locations